| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 83,327 | 79,182 | 69,162 | 58,370 |
| Cost of sales | 29,321 | 27,436 | 25,001 | 21,459 |
| Gross profit | 54,006 | 51,746 | 44,161 | 36,911 |
| Research and development | 18,187 | 17,632 | 16,402 | 16,647 |
| Selling, general and administrative | 59,011 | 56,303 | 55,197 | 42,691 |
| Total operating expenses | 77,198 | 73,935 | 71,599 | 59,338 |
| Loss from operations | -23,192 | -22,189 | -27,438 | -22,427 |
| Interest expense | 919 | 895 | 877 | 1,140 |
| Interest and other income, net | 2,700 | 3,506 | 3,578 | 2,593 |
| Net loss | -21,411 | -19,578 | -24,737 | -20,974 |
| Foreign currency translation adjustment | 186 | -367 | 109 | - |
| Unrealized gain on cash equivalents | 0 | 0 | - | -17 |
| Comprehensive loss | -21,225 | -19,945 | -24,628 | -20,991 |
| Basic (in shares) | 55,727,000 | 55,445,000 | 54,917,000 | 52,011,000 |
| Diluted (in shares) | 55,727,000 | 55,445,000 | 54,917,000 | 52,011,000 |
| Net loss per share, basic (in dollars per share) | -0.38 | -0.35 | -0.45 | -0.4 |
| Net loss per share, diluted (in dollars per share) | -0.38 | -0.35 | -0.45 | -0.4 |
PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corp (PRCT)